Why the study?
Are clotting factor levels (AHA, AHC) elevated in patients with coronary atherosclerosis compared to healthy controls?
Are clotting factor levels (AHA, AHC) elevated in patients with coronary atherosclerosis compared to healthy controls?
Patients with coronary atherosclerosis have higher average levels of antihemophilic A factor compared to healthy individuals, regardless of anticoagulant treatment.
Higher AHA levels in atherosclerosis should not change practice; leaves open causal or prognostic role pending prospective studies.
The clotting system was studied in a number of patients with coronary atherosclerotic disease, with special regard to antihemophilic A factor (AHA) and antihemophilic C factor (AHC).The levels of a number of clotting factors were determined in plasma samples from 14 patients with atherosclerotic coronary disease before the start of anticoagulant treatment. A similar study was made in 80 patients with the same disease under long-term anticoagulant treatment with phenylindanedione or dicoumarol for more than 3 months.AHA was found on the average higher in both groups of patients than in a group of 30 normal healthy persons. The AHA values did not seem to be definitely correlated with age, judged from the variations within the group of normal persons and within the group of treated patients. The high AHA values were not found to he correlated in any definite way with the duration of the anticoagulant treatment.The investigations confirmed the findings of other workers that average fibrinogen levels in these ...
No takes yet. Share an insight, caveat, or question.
O. Egeberg (1962) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: